A carregar...
Comparison of the Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil vs Valsartan by Ambulatory Blood Pressure Monitoring
J Clin Hypertens (Greenwich). 2011;13:467–472. ©2011 Wiley Periodicals, Inc. Azilsartan medoxomil (AZL‐M) is a unique angiotensin II receptor blocker (ARB) under development for the treatment of hypertension. To compare this ARB with another in the class, the authors studied the effects of AZL‐M and...
Na minha lista:
| Publicado no: | J Clin Hypertens (Greenwich) |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Ltd
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8108745/ https://ncbi.nlm.nih.gov/pubmed/21762358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2011.00482.x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|